Prospective Evaluation of Patient Priorities in HPV-Driven Oropharyngeal Cancer Using the Chicago Priorities Scale: Considerations for Future Clinical Trial Design

  • 0Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.

Summary

This summary is machine-generated.

Patient priorities for human papillomavirus-associated oropharyngeal cancer (HPVOPC) treatment remain consistent before and after chemoradiotherapy. Swallowing, senses, and mouth moisture become more important post-treatment for HPVOPC survivors.

Area Of Science

  • Oncology
  • Head and Neck Cancer Research
  • Patient-Reported Outcomes

Background

  • Human papillomavirus-associated oropharyngeal cancer (HPVOPC) is a distinct subtype of head and neck cancer.
  • Treatment priorities can evolve during and after oncological therapies.
  • Understanding patient priorities is crucial for tailoring treatment and supportive care.

Purpose Of The Study

  • To assess the treatment outcome priorities of HPVOPC patients before and 12 months after chemoradiotherapy (CRT).
  • To identify shifts in patient priorities regarding cure, survival, and quality of life post-treatment.
  • To inform the development of future de-escalation treatment strategies for HPVOPC.

Main Methods

  • A cohort of HPVOPC patients undergoing curative-intent primary CRT was studied.
  • The Chicago Priorities Scale (CPS-modified) and MDASI Head and Neck Cancer Module (MDASI-HN) were administered.
  • Descriptive statistics and statistical tests (McNemar's, general linear models) were used for analysis.

Main Results

  • Key priorities like cancer cure and survival remained stable pre- and post-CRT.
  • The ability to swallow was a top priority for 56% of patients post-CRT.
  • Increased importance was noted for senses (taste/smell) and moist mouth post-CRT.

Conclusions

  • Treatment outcome priorities for HPVOPC patients are largely stable before and 12 months after CRT.
  • A significant proportion of survivors prioritize swallowing, senses, and mouth moisture post-treatment.
  • Patient-centered priorities should guide the design of future de-escalation strategies in HPVOPC management.

Related Concept Videos

Cancer Survival Analysis 01:21

445

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Treatment Resistant Cancers 02:56

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Nursing Ethical Principles II 01:27

1.3K

Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

Clinical Trials: Overview 01:11

3.4K

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Cancer Vaccines 01:30

509

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Clinical Trials 01:16

7.5K

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...